Concepedia

Jay Lin

JL

92

Publications

5.4K

Citations

32

H-Index

2006

Active since

Affiliations

Sanofi (United States)(Current)

University of California, Irvine

IQVIA (United States)

Ochsner Medical Center

Pfizer (United States)

Jay Lin is an author at Sanofi (United States) specializing in medicine, public health, and outcomes research.

ORCID

Top concepts

Publications per year

2006–2021

92

Publications

92

Increasing Prevalence of Atrial Fibrillation and Flutter in the United States

Gerald V. Naccarelli, Helen Varker, Jay Lin et al. · The American Journal of Cardiology · 2009 · 859 citations

, , +8

Incidence and predictors of venous thromboembolism (VTE) among ambulatory high‐risk cancer patients undergoing chemotherapy in the United States

Alok A. Khorana, Mehul Dalal, Jay Lin et al. · Cancer · 2012 · 478 citations

Direct Medical Costs of Venous Thromboembolism and Subsequent Hospital Readmission Rates: An Administrative Claims Analysis From 30 Managed Care Organizations

Alex C. Spyropoulos, Jay Lin · Journal of Managed Care Pharmacy · 2007 · 331 citations · Full text

Economic burden of deep-vein thrombosis, pulmonary embolism, and post-thrombotic syndrome

D. MacDougall, Anthony L. Feliu, Stephen J. Boccuzzi et al. · American Journal of Health-System Pharmacy · 2006 · 300 citations

Prevalence of clinical venous thromboembolism in the USA: Current trends and future projections

Steven Deitelzweig, Barbara H. Johnson, Jay Lin et al. · American Journal of Hematology · 2010 · 245 citations

, , +20

Rows per page

1–5 of 92